Inovio Pharmaceuticals, Inc. (INO)
NASDAQ·Healthcare·Biotechnology
$0.68
-2.78%
Mkt Cap $36.28M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (6 analysts)
$2.50
Range $2.50 – $2.50
Implied Upside
+265.0%
Consensus $2.50 vs current $0.68
NASDAQ·Healthcare·Biotechnology
$0.68
-2.78%
Mkt Cap $36.28M
Buy
0
Hold
1
Sell
0
Price Target (6 analysts)
$2.50
Range $2.50 – $2.50
+265.0%
Consensus $2.50 vs current $0.68